Global Anal Fissure Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Anal Fissure Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

An anal fissure is a break or tear in the skin of the anal canal. Anal fissures may be noticed by bright red anal bleeding on toilet paper and undergarments, or sometimes in the toilet. If acute they are painful after defecation, but with chronic fissures, pain intensity often reduces. The condition is not life threatening but significantly affects the quality of person’s life.

The anal fissure treatment may include Topical nitroglycerin, Calcium channel blockers, Stool softeners and others. These treatments can relax the internal anal sphincter and increase blood flow to the affected area have been proven to be effective in reducing the healing time with success rates.

Market Overview:

The latest research study on the global Anal Fissure Treatment market finds that the global Anal Fissure Treatment market reached a value of USD 2014.6 million in 2022. It’s expected that the market will achieve USD 2813.7 million by 2028, exhibiting a CAGR of 5.73% during the forecast period.

Market Opportunities and Drivers

Constipation is a condition where the individual might have stools that are difficult or painful to pass being hard, dry, or lumpy. However, long-lasting constipation may have complications, such as hemorrhoids, anal fissures, rectal prolapse, and others. According to a recent survey by the American Gastroenterological Association, 16% of Americans suffer from chronic constipation, and nearly 33% over the age of 60 experience the condition. This leads to almost 6 million visits to the doctors’ offices or clinics and nearly 700,000 visits to emergency rooms every year.
Furthermore, according to the survey conducted by IPSOS, a market research firm, and Abbott India in 2018, 22% of the adult Indian population suffer from constipation, with 13% complaining of severe constipation. However, when the same survey was conducted by Abbott India and IPSOS in 2015, which found that 14% people in urban India suffer from chronic constipation and incidents of chronic constipation was over 10% worldwide. Thus, the growing incidences of constipation related problems worldwide are driving the growth of anal fissure treatment market.

Therefore, the growing prevalence of constipation is one of the main reasons causing the anal fissure, which in turn, propelling the market for anal fissure treatment.

Moreover, bad eating habits, leading to stressful and hectic life, and sedentary lifestyle observed among all age groups are also driving the market for anal fissure treatment.
The increasing consumption of fast food and improper eating habits are creating intestinal problems in the population. Additionally, some food allergies are also responsible for causing immune system problems, diarrhea or chronic constipation that would increase the demand for anal fissure treatment products. According to the United Nations International Children's Emergency Fund (UNICEF) data, worldwide 480,000 young children are dying every year due to diarrhea. The increasing prevalence of diarrhea among children may increase the demand for anal fissure treatment. And, the rise in the geriatric population who are at a higher risk of developing anal fissures owing to decreased blood flow to the anus is also a chief driver of the market.

Region Overview:

From 2023-2028, Asia-Pacific is estimated to witness robust growth prospects.

Company Overview:

PurduePharma is one of the major players operating in the Anal Fissure Treatment market, holding a share of 1.13% in 2020.

Purdue Pharma L.P. manufactures pharmaceutical products. The Company researches, develops, produces, and markets prescription and over-the-counter medicines and healthcare products such as pain medication, laxatives, first aid products, and dietary supplements. Purdue Pharma conducts business operations in the United States.

Allergan, Inc. provides pharmaceuticals products. The Company offers medical devices and over-the-counter products for ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, and urological diseases.

Allergan is now part of AbbVie.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. It strives to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Segmentation Overview:

Among different product types, Topical nitroglycerin segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Anal Fissure Treatment market covered in Chapter 3:

Takeda Pharmaceutical
Cadila Pharmaceuticals Ltd
Abbott Laboratories
Taj Pharmaceuticals
Sanofi
PurduePharma
Novasep
Troikaa Pharmaceuticals
Allergan Inc.
Healthy Life Pharma
Amato Pharmaceutical Products, Ltd.
Bayer AG

In Chapter 4 and Chapter 14.2, on the basis of types, the Anal Fissure Treatment market from 2018 to 2029 is primarily split into:

Topical nitroglycerin
Calcium channel blockers
Stool softeners
Other

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Anal Fissure Treatment market from 2018 to 2029 covers:

Clinics
Hospitals
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)